✦ LIBER ✦

PCN70 COST-EFFECTIVENESS ANALYSIS OF RITUXIMAB THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN BRAZIL

✍ Scribed by CS Chiattone; LG Borges; E Santos

Book ID: 118614160
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 76 KB
Volume: 13
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(11)71965-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN109 COST-EFFECTIVENESS OF RITUXIMAB I

PCN109 COST-EFFECTIVENESS OF RITUXIMAB IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN THE DUTCH SETTING

✍ M Pompen; G ten Hoor; E Carr; R Aultman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN71 COST-EFFECTIVENESS OF RITUXIMAB CO

PCN71 COST-EFFECTIVENESS OF RITUXIMAB COMBINED WITH FLUDARABINE AND CYCLOPHOSPHAMIDE IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN FRANCE

✍ M Roussel; X Troussard; A Delmer; M Poinso; H Miadi-Fargier 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Pentostatin, cyclophosphamide, and ritux

Pentostatin, cyclophosphamide, and rituximab show significant clinical activity in patients with previously untreated chronic lymphocytic leukemia

✍ Nicole Lamanna; Mark A. Weiss 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 116 KB

Chemoimmunotherapy with O-FC in previous

Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia

✍ Wierda, W. G.; Kipps, T. J.; Durig, J.; Griskevicius, L.; Stilgenbauer, S.; Maye 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 413 KB

Bendamustine in Combination With Rituxim

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Bottcher, S.; Bahlo, J.; Schubert, J.; Pflug 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB

Thalidomide and dexamethasone therapy of

Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemia

✍ James C. Barton 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 2 views

## Abstract A 67‐year‐old woman with previously untreated lambda‐positive B‐chronic lymphocytic leukemia (CLL) had kappa‐positive myeloma develop that was treated with daily thalidomide and intermittent dexamethasone. After 4 months, there was a marked reduction in marrow plasmacytosis, urine kappa